The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Factors affecting the physical stability (aggregation) of peptide therapeutics
Open accessAbstract
The number of biological therapeutic agents in the clinic and development pipeline has increased dramatically over the last decade and the number will undoubtedly continue to increase in the coming years. Despite this fact, there are considerable challenges in the development, production and formulation of such biologics particularly with respect to their physical stabilities. There are many cases where self-association to form either amorphous aggregates or highly structured fibrillar species limits their use. Here, we review the numerous factors that influence the physical stability of peptides including both intrinsic and external factors, wherever possible illustrating these with examples that are of therapeutic interest. The effects of sequence, concentration, pH, net charge, excipients, chemical degradation and modification, surfaces and interfaces, and impurities are all discussed. In addition, the effects of physical parameters such as pressure, temperature, agitation and lyophilization are described. We provide an overview of the structures of aggregates formed, as well as our current knowledge of the mechanisms for their formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The amyloid state and its association with protein misfolding diseases.
Knowles, T. P. J., Vendruscolo, M., & Dobson, C. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3810 · Cited by 2,382
The Amyloid State of Proteins in Human Diseases
Eisenberg, D., & Jucker, M. (2012) · Cell · doi:10.1016/j.cell.2012.02.022 · Cited by 1,744
Understanding protein adsorption phenomena at solid surfaces
Rabe, M., Verdes, D., & Seeger, S. (2011) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2010.12.007 · Cited by 1,664
Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins
Fernandez-Escamilla, A.-M., Rousseau, F., Schymkowitz, J., & Serrano, L. (2004) · Nature Biotechnology · doi:10.1038/nbt1012 · Cited by 1,658
Stability of Protein Pharmaceuticals: An Update
Manning, M. C., Chou, D. K., Murphy, B. M., Payne, R. W., & Katayama, D. S. (2010) · Pharmaceutical Research · doi:10.1007/s11095-009-0045-6 · Cited by 1,098
Protein drug stability: a formulation challenge
Frokjaer, S., & Otzen, D. E. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1695 · Cited by 1,096
Stability of Protein Pharmaceuticals
Manning, M. C., Patel, K., & Borchardt, R. T. (1989) · Pharmaceutical Research · doi:10.1023/a:1015929109894 · Cited by 1,078
Rationalization of the effects of mutations on peptide andprotein aggregation rates
Chiti, F., Stefani, M., Taddei, N., Ramponi, G., & Dobson, C. M. (2003) · Nature · doi:10.1038/nature01891 · Cited by 1,072
AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides
Conchillo-Solé, O., de Groot, N. S., Avilés, F. X., Vendrell, J., Daura, X., & Ventura, S. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-65 · Cited by 1,068
Instability, stabilization, and formulation of liquid protein pharmaceuticals
Wang, W. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00152-0 · Cited by 1,064
Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48529-8 · Cited by 1,014
Protein aggregation and its inhibition in biopharmaceutics
Wang, W. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.11.014 · Cited by 983
Alzheimer’s amyloid fibrils: structure and assembly
Serpell, L. C. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00029-6 · Cited by 959
The protofilament structure of insulin amyloid fibrils
Jiménez, J. L., Nettleton, E. J., Bouchard, M., Robinson, C. V., Dobson, C. M., & Saibil, H. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142459399 · Cited by 834
Protein aggregation—Pathways and influencing factors
Wang, W., Nema, S., & Teagarden, D. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.02.025 · Cited by 806
Kerwin, B. A. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21190 · Cited by 792
Nanomechanics of functional and pathological amyloid materials
Knowles, T. P. J., & Buehler, M. J. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.102 · Cited by 784
Molecular mechanisms of protein aggregation from global fitting of kinetic models
Meisl, G., Kirkegaard, J. B., Arosio, P., Michaels, T. C. T., Vendruscolo, M., Dobson, C. M., Linse, S., & Knowles, T. P. J. (2016) · Nature Protocols · doi:10.1038/nprot.2016.010 · Cited by 767
On the lag phase in amyloid fibril formation
Arosio, P., Knowles, T. P. J., & Linse, S. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c4cp05563b · Cited by 766
Protein Interactions with Polymer Coatings and Biomaterials
Wei, Q., Becherer, T., Angioletti‐Uberti, S., Dzubiella, J., Wischke, C., Neffe, A. T., Lendlein, A., Ballauff, M., & Haag, R. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201400546 · Cited by 743
Exploring the sequence determinants of amyloid structure using position-specific scoring matrices
Maurer-Stroh, S., Debulpaep, M., Kuemmerer, N., de la Paz, M. L., Martins, I. C., Reumers, J., Morris, K. L., Copland, A., Serpell, L., Serrano, L., et al. (2010) · Nature Methods · doi:10.1038/nmeth.1432 · Cited by 680
Characterization of the nanoscale properties of individual amyloid fibrils
Smith, J. F., Knowles, T. P. J., Dobson, C. M., MacPhee, C. E., & Welland, M. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604035103 · Cited by 640
Protein–surfactant interactions: A tale of many states
Otzen, D. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.03.003 · Cited by 637
Pawar, A. P., DuBay, K. F., Zurdo, J., Chiti, F., Vendruscolo, M., & Dobson, C. M. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.04.016 · Cited by 588
Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease
Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C. L., & Beyreuther, K. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90881-6 · Cited by 580
Luca, S., Yau, W.-M., Leapman, R., & Tycko, R. (2007) · Biochemistry · doi:10.1021/bi701427q · Cited by 578
Immunogenicity of Therapeutic Protein Aggregates
Moussa, E. M., Panchal, J. P., Moorthy, B. S., Blum, J. S., Joubert, M. K., Narhi, L. O., & Topp, E. M. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.002 · Cited by 529
Protein adsorption on solid surfaces
Hlady, V., & Buijs, J. (1996) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(96)80098-x · Cited by 522
Kamerzell, T. J., Esfandiary, R., Joshi, S. B., Middaugh, C. R., & Volkin, D. B. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.07.006 · Cited by 510
The activities of amyloids from a structural perspective
Riek, R., & Eisenberg, D. S. (2016) · Nature · doi:10.1038/nature20416 · Cited by 508
PASTA 2.0: an improved server for protein aggregation prediction
Walsh, I., Seno, F., Tosatto, S. C. E., & Trovato, A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku399 · Cited by 472
Prediction of Aggregation-Prone Regions in Structured Proteins
Tartaglia, G. G., Pawar, A. P., Campioni, S., Dobson, C. M., Chiti, F., & Vendruscolo, M. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.05.013 · Cited by 437
Kowalewski, T., & Holtzman, D. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3688 · Cited by 406
Interactions of formulation excipients with proteins in solution and in the dried state
Ohtake, S., Kita, Y., & Arakawa, T. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.011 · Cited by 398
The 3D profile method for identifying fibril-forming segments of proteins
Thompson, M. J., Sievers, S. A., Karanicolas, J., Ivanova, M. I., Baker, D., & Eisenberg, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511295103 · Cited by 395
Nick Pace, C., Scholtz, J. M., & Grimsley, G. R. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.05.006 · Cited by 386
Protein palmitoylation and subcellular trafficking
Aicart-Ramos, C., Valero, R. A., & Rodriguez-Crespo, I. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.07.009 · Cited by 372
The protofilament substructure of amyloid fibrils11Edited by F. E. Cohen
Serpell, L. C., Sunde, M., Benson, M. D., Tennent, G. A., Pepys, M. B., & Fraser, P. E. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3908 · Cited by 342
Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer’s disease
Thal, D. R., Walter, J., Saido, T. C., & Fändrich, M. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1375-y · Cited by 319
Prediction of the Absolute Aggregation Rates of Amyloidogenic Polypeptide Chains
DuBay, K. F., Pawar, A. P., Chiti, F., Zurdo, J., Dobson, C. M., & Vendruscolo, M. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.06.043 · Cited by 318
The Common Architecture of Cross-β Amyloid
Jahn, T. R., Makin, O. S., Morris, K. L., Marshall, K. E., Tian, P., Sikorski, P., & Serpell, L. C. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.09.039 · Cited by 304
Kishore, R. S. K., Kiese, S., Fischer, S., Pappenberger, A., Grauschopf, U., & Mahler, H.-C. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0385-x · Cited by 299
Freeze‐drying of proteins: some emerging concerns
Roy, I., & Gupta, M. N. (2004) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20030133 · Cited by 288
Key interactions of surfactants in therapeutic protein formulations: A review
Khan, T. A., Mahler, H.-C., & Kishore, R. S. K. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.09.016 · Cited by 287
Peroxide formation in polysorbate 80 and protein stability
Ha, E., Wang, W., & John Wang, Y. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10216 · Cited by 286
Degradation of Polysorbates 20 and 80: Studies on Thermal Autoxidation and Hydrolysis
Kishore, R. S. K., Pappenberger, A., Dauphin, I. B., Ross, A., Buergi, B., Staempfli, A., & Mahler, H.-C. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22290 · Cited by 285
Lashuel, H. A., LaBrenz, S. R., Woo, L., Serpell, L. C., & Kelly, J. W. (2000) · Journal of the American Chemical Society · doi:10.1021/ja9937831 · Cited by 285
Peptidomimetic therapeutics: scientific approaches and opportunities
Qvit, N., Rubin, S. J. S., Urban, T. J., Mochly-Rosen, D., & Gross, E. R. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.11.003 · Cited by 273
Immunogenicity of protein aggregates—Concerns and realities
Wang, W., Singh, S. K., Li, N., Toler, M. R., King, K. R., & Nema, S. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.040 · Cited by 266
Antioxidants for Prevention of Methionine Oxidation in Recombinant Monoclonal Antibody HER2
Lam, X. M., Yang, J. Y., & Cleland, J. L. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js970143s · Cited by 263
Fezoui, Y., Hartley, D. M., Harper, J. D., Khurana, R., Walsh, D. M., Condron, M. M., Selkoe, D. J., Lansbury, P. T., Fink, A. L., & Teplow, D. B. (2000) · Amyloid · doi:10.3109/13506120009146831 · Cited by 260
Molecular origins of surfactant-mediated stabilization of protein drugs
Lee, H. J., McAuley, A., Schilke, K. F., & McGuire, J. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.015 · Cited by 258
Wakankar, A. A., & Borchardt, R. T. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20740 · Cited by 254
Mechanism of Insulin Fibrillation
Hua, Q.-X., & Weiss, M. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314141200 · Cited by 253
Structural Basis for Increased Toxicity of Pathological Aβ42:Aβ40 Ratios in Alzheimer Disease
Pauwels, K., Williams, T. L., Morris, K. L., Jonckheere, W., Vandersteen, A., Kelly, G., Schymkowitz, J., Rousseau, F., Pastore, A., Serpell, L. C., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.264473 · Cited by 253
Review self‐assembly of amphipathic β‐sheet peptides: Insights and applications
Bowerman, C. J., & Nilsson, B. L. (2012) · Peptide Science · doi:10.1002/bip.22058 · Cited by 244
The PASTA server for protein aggregation prediction
Trovato, A., Seno, F., & Tosatto, S. C. E. (2007) · Protein Engineering Design and Selection · doi:10.1093/protein/gzm042 · Cited by 243
Modeling and simulation of protein–surface interactions: achievements and challenges
Ozboyaci, M., Kokh, D. B., Corni, S., & Wade, R. C. (2016) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583515000256 · Cited by 237
The Changing Face of Glucagon Fibrillation: Structural Polymorphism and Conformational Imprinting
Pedersen, J. S., Dikov, D., Flink, J. L., Hjuler, H. A., Christiansen, G., & Otzen, D. E. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.100 · Cited by 235
Glaser, C. B., Morser, J., Clarke, J. H., Blasko, E., McLean, K., Kuhn, I., Chang, R. J., Lin, J. H., Vilander, L., & Andrews, W. H. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116151 · Cited by 233
Marshall, K. E., Morris, K. L., Charlton, D., O’Reilly, N., Lewis, L., Walden, H., & Serpell, L. C. (2011) · Biochemistry · doi:10.1021/bi101936c · Cited by 232
Pyroglutamate Formation Influences Solubility and Amyloidogenicity of Amyloid Peptides
Schlenzig, D., Manhart, S., Cinar, Y., Kleinschmidt, M., Hause, G., Willbold, D., Funke, S. A., Schilling, S., & Demuth, H.-U. (2009) · Biochemistry · doi:10.1021/bi900818a · Cited by 228
Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading
Iljina, M., Garcia, G. A., Horrocks, M. H., Tosatto, L., Choi, M. L., Ganzinger, K. A., Abramov, A. Y., Gandhi, S., Wood, N. W., Cremades, N., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524128113 · Cited by 225
Oxidation of Therapeutic Proteins and Peptides: Structural and Biological Consequences
Torosantucci, R., Schöneich, C., & Jiskoot, W. (2014) · Pharmaceutical Research · doi:10.1007/s11095-013-1199-9 · Cited by 215
Modelling amyloid fibril formation kinetics: mechanisms of nucleation and growth
Gillam, J. E., & MacPhee, C. E. (2013) · Journal of Physics: Condensed Matter · doi:10.1088/0953-8984/25/37/373101 · Cited by 215
Kinetics of antigen-antibody reactions at solid-liquid interfaces
Stenberg, M., & Nygren, H. (1988) · Journal of Immunological Methods · doi:10.1016/0022-1759(88)90376-6 · Cited by 215
Ji, J. A., Zhang, B., Cheng, W., & Wang, Y. J. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21746 · Cited by 215
Klement, K., Wieligmann, K., Meinhardt, J., Hortschansky, P., Richter, W., & Fändrich, M. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.08.068 · Cited by 209
Prediction of "hot spots" of aggregation in disease-linked polypeptides
de Groot, N. S., Pallarés, I., Avilés, F. X., Vendrell, J., & Ventura, S. (2005) · BMC Structural Biology · doi:10.1186/1472-6807-5-18 · Cited by 204
Powers, E. T., & Powers, D. L. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.117168 · Cited by 204
Matthews, J. E., Stewart, M. W., De Boever, E. H., Dobbins, R. L., Hodge, R. J., Walker, S. E., Holland, M. C., Bush, M. A., & for the Albiglutide Study Group (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1518 · Cited by 198
McCutchen, S. L., Colon, W., & Kelly, J. W. (1993) · Biochemistry · doi:10.1021/bi00096a024 · Cited by 197
A mechanistic model of tau amyloid aggregation based on direct observation of oligomers
Shammas, S. L., Garcia, G. A., Kumar, S., Kjaergaard, M., Horrocks, M. H., Shivji, N., Mandelkow, E., Knowles, T. P. J., Mandelkow, E., & Klenerman, D. (2015) · Nature Communications · doi:10.1038/ncomms8025 · Cited by 195
Role of Buffers in Protein Formulations
Zbacnik, T. J., Holcomb, R. E., Katayama, D. S., Murphy, B. M., Payne, R. W., Coccaro, R. C., Evans, G. J., Matsuura, J. E., Henry, C. S., & Manning, M. C. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.11.014 · Cited by 195
The Pathway by Which the Tetrameric Protein Transthyretin Dissociates
Foss, T. R., Wiseman, R. L., & Kelly, J. W. (2005) · Biochemistry · doi:10.1021/bi051608t · Cited by 193
Dual effects of Tween 80 on protein stability
Wang, W., Wang, Y. J., & Wang, D. Q. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.042 · Cited by 192
Stabilization of proteins in solid form
Cicerone, M. T., Pikal, M. J., & Qian, K. K. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.006 · Cited by 188
Antimicrobial preservative use in parenteral products: Past and present
Meyer, B. K., Ni, A., Hu, B., & Shi, L. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20976 · Cited by 187
Bush, M. A., Matthews, J. E., De Boever, E. H., Dobbins, R. L., Hodge, R. J., Walker, S. E., Holland, M. C., Gutierrez, M., & Stewart, M. W. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00992.x · Cited by 181
Prediction of Amyloidogenic and Disordered Regions in Protein Chains
Galzitskaya, O. V., Garbuzynskiy, S. O., & Lobanov, M. Y. (2006) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0020177 · Cited by 175
Nettleton, E. J., Sunde, M., Lai, Z., Kelly, J. W., Dobson, C. M., & Robinson, C. V. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1937 · Cited by 174
Structure and Composition of Insulin Fibril Surfaces Probed by TERS
Kurouski, D., Deckert-Gaudig, T., Deckert, V., & Lednev, I. K. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303263y · Cited by 172
Marek, P. J., Patsalo, V., Green, D. F., & Raleigh, D. P. (2012) · Biochemistry · doi:10.1021/bi300574r · Cited by 168
Raman, B., Chatani, E., Kihara, M., Ban, T., Sakai, M., Hasegawa, K., Naiki, H., Rao, C. M., & Goto, Y. (2005) · Biochemistry · doi:10.1021/bi048029t · Cited by 168
Finder, V. H., Vodopivec, I., Nitsch, R. M., & Glockshuber, R. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.12.016 · Cited by 168
Jiang, X., Buxbaum, J. N., & Kelly, J. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261419998 · Cited by 166
Bartels, T., Kim, N. C., Luth, E. S., & Selkoe, D. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103727 · Cited by 164
Xiang, W., Schlachetzki, J. C. M., Helling, S., Bussmann, J., Berlinghof, M., Schäffer, T. E., Marcus, K., Winkler, J., Klucken, J., & Becker, C. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.01.004 · Cited by 160
Effects of Surfaces and Leachables on the Stability of Biopharmaceuticals
Bee, J. S., Randolph, T. W., Carpenter, J. F., Bishop, S. M., & Dimitrova, M. N. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22597 · Cited by 160
Effect of Surfaces on Amyloid Fibril Formation
Moores, B., Drolle, E., Attwood, S. J., Simons, J., & Leonenko, Z. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025954 · Cited by 158
Non-Arrhenius Protein Aggregation
Wang, W., & Roberts, C. J. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9485-3 · Cited by 158
Fibril Structure of Human Islet Amyloid Polypeptide
Bedrood, S., Li, Y., Isas, J. M., Hegde, B. G., Baxa, U., Haworth, I. S., & Langen, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.327817 · Cited by 152
Structural Characterisation of Islet Amyloid Polypeptide Fibrils
Makin, O. S., & Serpell, L. C. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.11.048 · Cited by 147
Insulin aggregation in artificial delivery systems
Lougheed, W. D., Woulfe-Flanagan, H., Clement, J. R., & Albisser, A. M. (1980) · Diabetologia · doi:10.1007/bf00258302 · Cited by 145
Agrawal, N. J., Kumar, S., Wang, X., Helk, B., Singh, S. K., & Trout, B. L. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22705 · Cited by 144
Hermeling, S., Caetano, L. A., Damen, M. J. A., Slijper, M., Schellekens, H., Crommelin, D. J. A., & Jiskoot, W. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8177-9 · Cited by 144
Nature and Significance of the Interactions between Amyloid Fibrils and Biological Polyelectrolytes
Calamai, M., Kumita, J. R., Mifsud, J., Parrini, C., Ramazzotti, M., Ramponi, G., Taddei, N., Chiti, F., & Dobson, C. M. (2006) · Biochemistry · doi:10.1021/bi0610653 · Cited by 142
Pathogenesis of and Therapeutic Strategies to Ameliorate the Transthyretin Amyloidoses
Sekijima, Y., Kelly, J. W., & Ikeda, S. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786404155 · Cited by 139
Deamidation destabilizes and triggers aggregation of a lens protein, βA3‐crystallin
Takata, T., Oxford, J. T., Demeler, B., & Lampi, K. J. (2008) · Protein Science · doi:10.1110/ps.035410.108 · Cited by 132
Bae, E.-J., Ho, D. H., Park, E., Jung, J. W., Cho, K., Hong, J. H., Lee, H.-J., Kim, K. P., & Lee, S. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4429 · Cited by 131
Tomlinson, A. A. G., Demeule, B., Lin, B., et al. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00311 · Cited by 130
Amyloid–β-Sheet Formation at the Air-Water Interface
Schladitz, C., Vieira, E. P., Hermel, H., et al. (1999) · Biophysical Journal · doi:10.1016/s0006-3495(99)77161-4 · Cited by 126
A de novo designed helix-turn-helix peptide forms nontoxic amyloid fibrils.
Fezoui, Y., Teplow, D. B., Hartley, D. M., Walsh, D. M., Selkoe, D. J., & Osterhout, J. J. (2000) · Nature Structural Biology · doi:10.1038/81937 · Cited by 124
Nilsson, M. R., Driscoll, M., & Raleigh, D. P. (2002) · Protein Science · doi:10.1110/ps.48702 · Cited by 124
BETASCAN: Probable β-amyloids Identified by Pairwise Probabilistic Analysis
Bryan, A. W., Menke, M. E., Cowen, L., Lindquist, S. L., & Berger, B. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000333 · Cited by 122
Cold‐ and Pressure‐Induced Dissociation of Protein Aggregates and Amyloid Fibrils
Mishra, R. K., & Winter, R. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200802027 · Cited by 121
Zhang, Z., Chen, H., & Lai, L. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm325 · Cited by 120
Amyloid structure – one but not the same: the many levels of fibrillar polymorphism
Pedersen, J. S., Andersen, C. B., & Otzen, D. E. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07888.x · Cited by 119
Salt-Induced Modulation of the Pathway of Amyloid Fibril Formation by the Mouse Prion Protein
Jain, S., & Udgaonkar, J. B. (2010) · Biochemistry · doi:10.1021/bi100745j · Cited by 117
Zibaee, S., Makin, O. S., Goedert, M., & Serpell, L. C. (2007) · Protein Science · doi:10.1110/ps.062624507 · Cited by 116
Assays for α-synuclein aggregation
Giehm, L., Lorenzen, N., & Otzen, D. E. (2010) · Methods · doi:10.1016/j.ymeth.2010.12.008 · Cited by 115
Yun, S., Urbanc, B., Cruz, L., Bitan, G., Teplow, D. B., & Stanley, E. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.097766 · Cited by 115
Influence of Hydrophobic Teflon Particles on the Structure of Amyloid β-Peptide
Giacomelli, C. E., & Norde, W. (2003) · Biomacromolecules · doi:10.1021/bm034151g · Cited by 113
pH Dependence of Amylin Fibrillization
Jha, S., Snell, J. M., Sheftic, S. R., Patil, S. M., Daniels, S. B., Kolling, F. W., & Alexandrescu, A. T. (2013) · Biochemistry · doi:10.1021/bi401164k · Cited by 113
Formulation Design of Acidic Fibroblast Growth Factor
Tsai, P. K., Volkin, D. B., Dabora, J. M., Thompson, K. C., Bruner, M. W., Gress, J., Matuszewska, B., Keogan, M., Bondi, J. V., & Middaugh, C. R. (1993) · Pharmaceutical Research · doi:10.1023/a:1018939228201 · Cited by 112
Kurouski, D., Dukor, R. K., Lu, X., Nafié, L. A., & Lednev, I. K. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.04.042 · Cited by 112
Kabiri, M., & Unsworth, L. D. (2014) · Biomacromolecules · doi:10.1021/bm5004515 · Cited by 111
Chen, F., David, D. C., Ferrari, A., & Götz, J. (2004) · Current Drug Targets · doi:10.2174/1389450043345236 · Cited by 107
Deamidation Accelerates Amyloid Formation and Alters Amylin Fiber Structure
Dunkelberger, E. B., Buchanan, L. E., Marek, P., Cao, P., Raleigh, D. P., & Zanni, M. T. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3039486 · Cited by 107
Glutaminyl cyclases from animals and plants: a case of functionally convergent protein evolution
Schilling, S., Wasternack, C., & Demuth, H. (2008) · Biological Chemistry · doi:10.1515/bc.2008.111 · Cited by 105
Kinetic Stabilization of an Oligomeric Protein by a Single Ligand Binding Event
Wiseman, R. L., Johnson, S. M., Kelker, M. S., Foss, T. R., Wilson, I. A., & Kelly, J. W. (2005) · Journal of the American Chemical Society · doi:10.1021/ja042929f · Cited by 104
HYDROTROPY: A PROMISING TOOL FOR SOLUBILITY ENHANCEMENT: A REVIEW
Nidhi, K., Indrajeet, S., Khushboo, M., et al. (2011) · International Journal of Drug Development and Research · Cited by 104
Conformational Changes of the Amyloid β‐Peptide (1–40) Adsorbed on Solid Surfaces
Giacomelli, C. E., & Norde, W. (2005) · Macromolecular Bioscience · doi:10.1002/mabi.200400189 · Cited by 103
Phosphorylation modifies the molecular stability of β-amyloid deposits
Rezaei‐Ghaleh, N., Amininasab, M., Kumar, S., Walter, J., & Zweckstetter, M. (2016) · Nature Communications · doi:10.1038/ncomms11359 · Cited by 102
Peptide lipidation stabilizes structure to enhance biological function
Ward, B. P., Ottaway, N. L., Perez-Tilve, D., Ma, D., Gelfanov, V. M., Tschöp, M. H., & DiMarchi, R. D. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.08.008 · Cited by 101
Sulfates Dramatically Stabilize a Salt-Dependent Type of Glucagon Fibrils
Pedersen, J. S., Flink, J. M., Dikov, D., & Otzen, D. E. (2006) · Biophysical Journal · doi:10.1529/biophysj.105.070912 · Cited by 100
Meisl, G., Yang, X., Frohm, B., Knowles, T. P. J., & Linse, S. S. (2016) · Scientific Reports · doi:10.1038/srep18728 · Cited by 97
Ionic Strength Modulation of the Free Energy Landscape of Aβ 40 Peptide Fibril Formation
Abelein, A., Jarvet, J., Barth, A., Gräslund, A., & Danielsson, J. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b04511 · Cited by 97
Iyer, A., Roeters, S. J., Schilderink, N., Hommersom, B., Heeren, R. M. A., Woutersen, S., Claessens, M. M. A. E., & Subramaniam, V. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.726612 · Cited by 97
Protein aggregation: more than just fibrils
Krebs, M. R. H., Domike, K. R., & Donald, A. M. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370682 · Cited by 96
The Effect of Osmolytes on Protein Fibrillation
Macchi, F., Eisenkolb, M., Kiefer, H., & Otzen, D. E. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13033801 · Cited by 93
Formulation and Stability of Cytokine Therapeutics
Lipiäinen, T., Peltoniemi, M., Sarkhel, S., Yrjönen, T., Vuorela, H. J., Urtti, A. O., & Juppo, A. M. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24243 · Cited by 91
Disulfide Bridges Remain Intact while Native Insulin Converts into Amyloid Fibrils
Kurouski, D., Washington, J. D., Özbil, M., Prabhakar, R. S., Shekhtman, A. G., & Lednev, I. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036989 · Cited by 90
Protein sequences encode safeguards against aggregation
Reumers, J., Maurer‐Stroh, S., Schymkowitz, J. W. H., & Rousseau, F. (2009) · Human Mutation · doi:10.1002/humu.20905 · Cited by 90
Transformation of Oligomers of Lipidated Peptide Induced by Change in pH
Wang, Y., Lomakin, A., Kanai, S., Alex, R., & Benedek, G. B. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500519s · Cited by 89
Spontaneous inter-conversion of insulin fibril chirality
Kurouski, D., Dukor, R. K., Lu, X., Nafié, L. A., & Lednev, I. K. (2011) · Chemical Communications · doi:10.1039/c2cc16895b · Cited by 88
Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C. L., & Beyreuther, K. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16256.x · Cited by 82
Doran, T. M., Kamens, A. J., Byrnes, N. K., & Nilsson, B. L. (2011) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24007 · Cited by 80
Pyroglutamate-Aβ: Role in the natural history of Alzheimer's disease
Gunn, A. P., Masters, C. L., & Cherny, R. A. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.08.015 · Cited by 79
Buell, A. K., Dobson, C. M., & Knowles, T. P. J. (2014) · Essays in Biochemistry · doi:10.1042/bse0560011 · Cited by 79
The Nature of Amyloid-like Glucagon Fibrils
Pedersen, J. S. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400609 · Cited by 78
Engineering disulfide bonds within an antibody
Hagihara, Y., & Saerens, D. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.07.005 · Cited by 78
Amyloid Fibrils of Glucagon Characterized by High-Resolution Atomic Force Microscopy
Jong, K. L. D., Incledon, B., Yip, C. M., & DeFelippis, M. R. (2006) · Biophysical Journal · doi:10.1529/biophysj.105.077438 · Cited by 77
Joshi, A. B., Sawai, M. V., Kearney, W. R., & Kirsch, L. E. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20405 · Cited by 76
Exploring the relationships between protein sequence, structure and solubility
Trainor, K., Broom, A., & Meiering, E. M. (2017) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2017.01.004 · Cited by 76
Immunochemistry at interfaces.
Nygren, H., & Stenberg, M. (1989) · PubMed · Cited by 75
Rabe, M., Soragni, A., Reynolds, N. P., Verdes, D., Liverani, E., Riek, R., & Seeger, S. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn3001312 · Cited by 75
Zhou, S., Zhang, B., Sturm, E. C., Teagarden, D. L., Schöneich, C., Kolhe, P., Lewis, L. M., Muralidhara, B. K., & Singh, S. K. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22141 · Cited by 72
Shen, C. L., Fitzgerald, M., & Murphy, R. M. (1994) · Biophysical Journal · doi:10.1016/s0006-3495(94)80593-4 · Cited by 71
The degradation pathways of glucagon in acidic solutions
Joshi, A. B., Rus, E., & Kirsch, L. E. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00438-5 · Cited by 70
Amyloid-β Peptide Nitrotyrosination Stabilizes Oligomers and Enhances NMDAR-Mediated Toxicity
Guivernau, B., Bonet, J., Valls-Comamala, V., Bosch-Morató, M., Godoy, J. A., Inestrosa, N. C., Perálvarez-Marín, A., Fernández-Busquets, X., Andreu, D., Oliva, B., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1081-16.2016 · Cited by 69
Effects of Phenol and meta-Cresol Depletion on Insulin Analog Stability at Physiological Temperature
Teska, B. M., Alarcón, J., Pettis, R. J., Randolph, T. W., & Carpenter, J. F. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24039 · Cited by 64
Zhang, Y., Roy, S., Jones, L. S., Krishnan, S., Kerwin, B. A., Chang, B. S., Manning, M. C., Randolph, T. W., & Carpenter, J. F. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20219 · Cited by 64
Controlled release of biologics for the treatment of type 2 diabetes
Gilroy, C. A., Luginbuhl, K. M., & Chilkoti, A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.002 · Cited by 64
Batzli, K. M., & Love, B. J. (2014) · Materials Science and Engineering C · doi:10.1016/j.msec.2014.09.015 · Cited by 62
Kerr, D. E., Wizemann, E., Senstius, J., Zacho, M., & Ampudia‐Blasco, F. J. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700620 · Cited by 62
Geoghegan, J. C., Fleming, R. L., Damschroder, M. M., Bishop, S. M., Sathish, H. A., & Esfandiary, R. (2016) · mAbs · doi:10.1080/19420862.2016.1171444 · Cited by 62
Lipopeptide detergents for membrane protein studies
Privé, G. G. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.07.008 · Cited by 61
Bye, J. W., Platts, L., & Falconer, R. J. (2014) · Biotechnology Letters · doi:10.1007/s10529-013-1445-6 · Cited by 61
Nault, L., Guo, P., Jain, B., Brechet, Y. J. M., Brückert, F., & Weidenhaupt, M. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.09.025 · Cited by 61
Predicting aggregation-prone sequences in proteins
Baets, G. D., Schymkowitz, J. W. H., & Rousseau, F. (2014) · Essays in Biochemistry · doi:10.1042/bse0560041 · Cited by 60
Surface chemistry at the nanometer scale influences insulin aggregation
Pandey, L. M., Denmat, S. L., Delabouglise, D., Brückert, F., Pattanayek, S. K., & Weidenhaupt, M. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.05.022 · Cited by 58
A pH-Induced Switch in Human Glucagon-like Peptide-1 Aggregation Kinetics
Zapadka, K. L., Becher, F. J., Uddin, S., Varley, P., Bishop, S., dos Santos, A. L. G., & Jackson, S. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b05025 · Cited by 55
Self-citationAmyloid-β Fibrillogenesis Seeded by Interface-Induced Peptide Misfolding and Self-Assembly
Chi, E. Y., Frey, S. L., Winans, A., Lam, K. L. H., Kjær, K., Majewski, J. P., & Lee, K. Y. C. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.01.056 · Cited by 54
A Mechanistic Model for Amorphous Protein Aggregation of Immunoglobulin-like Domains
Borgia, M. B., Nickson, A. A., Clarke, J., & Hounslow, M. J. (2013) · Journal of the American Chemical Society · doi:10.1021/ja308852b · Cited by 53
Early Engineering Approaches to Improve Peptide Developability and Manufacturability
Furman, J. L., Chiu, M. L., & Hunter, M. J. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9681-9 · Cited by 51
Mechanisms of glucagon degradation at alkaline pH
Caputo, N., Castle, J. R., Bergstrom, C. P., Carroll, J. M., Bakhtiani, P. A., Jackson, M. A., Roberts, C. T., David, L. L., & Ward, W. K. (2013) · Peptides · doi:10.1016/j.peptides.2013.04.005 · Cited by 48
Beerten, J., Jonckheere, W., Rudyak, S. G., Xu, J., Wilkinson, H., Smet, F. D., Schymkowitz, J. W. H., & Rousseau, F. (2012) · Protein Engineering Design and Selection · doi:10.1093/protein/gzs031 · Cited by 48
Li, Y., Wang, Y., Wei, Q., Zheng, X., Tang, L., Kong, D., & Gong, M. (2015) · Scientific Reports · doi:10.1038/srep18039 · Cited by 47
N- and C-Terminal Hydrophobic Patches Are Involved in Fibrillation of Glucagon
Pedersen, J. S., Dikov, D., & Otzen, D. E. (2006) · Biochemistry · doi:10.1021/bi061228n · Cited by 46
Weirich, F., Gremer, L., Mirecka, E. A., Schiefer, S., Hoyer, W., & Heise, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161243 · Cited by 45
Torosantucci, R., Sharov, V. S., van Beers, M. M. C., Brinks, V., Schöneich, C., & Jiskoot, W. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300665u · Cited by 44
Native metastable prefibrillar oligomers are the most neurotoxic species among amyloid aggregates
Diociaiuti, M., Macchia, G., Paradisi, S., Frank, C., Camerini, S., Chistolini, P., Gaudiano, M. C., Petrucci, T. C., & Malchiodi‐Albedi, F. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.006 · Cited by 44
Trier, S., Linderoth, L., Bjerregaard, S., Andresen, T. L., & Rahbek, U. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109939 · Cited by 43
Baets, G. D., Durme, J. V., Rousseau, F., & Schymkowitz, J. W. H. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.04.007 · Cited by 43
Kamihira, M., Oshiro, Y., Tuzi, S., Nosaka, A. Y., Saitô, H., & Naito, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205285200 · Cited by 42
Structural characterization of amyloid fibrils from the human parathyroid hormone
Gopalswamy, M., Kumar, A., Adler, J., Baumann, M., Henze, M., Kumar, S. T., Fändrich, M., Scheidt, H. A., Huster, D., & Balbach, J. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.12.020 · Cited by 42
Application of High Hydrostatic Pressure to Dissociate Aggregates and Refold Proteins
Seefeldt, M. B., Rosendahl, M. S., Cleland, J. L., & Hesterberg, L. K. (2009) · Current Pharmaceutical Biotechnology · doi:10.2174/138920109788488914 · Cited by 42
Hall, D. R., Kardos, J., Edskes, H. K., Carver, J. A., & Goto, Y. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.01.032 · Cited by 41
Trivella, D. B. B., Bleicher, L., Palmieri, L. D. C., Wiggers, H. J., Montanari, C. A., Kelly, J. W., Lima, L. M. T. R., Foguel, D., & Polikarpov, I. (2010) · Journal of Structural Biology · doi:10.1016/j.jsb.2010.03.002 · Cited by 41
Mechanisms of m-cresol-induced Protein Aggregation Studied Using a Model Protein Cytochrome c
Singh, S. M., Hutchings, R. L., & Mallela, K. M. G. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22426 · Cited by 40
Dissociation of Amyloid Fibrils of α‐Synuclein in Supercooled Water
Kim, H., Cho, M., Riedel, D., Fernández, C. O., & Zweckstetter, M. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800342 · Cited by 40
Joshi, A. B., & Kirsch, L. E. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10213 · Cited by 39
Characterization of Novel Insulin Fibrils That Show Strong Cytotoxicity Under Physiological pH
Yoshihara, H., Saito, J., Tanabe, A., Amada, T., Asakura, T., Kitagawa, K., & Asada, S. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.01.025 · Cited by 38
Gaudiano, M. C., Colone, M., Bombelli, C., Chistolini, P., Valvo, L., & Diociaiuti, M. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.04.008 · Cited by 34
GLP-1 analogs containing disulfide bond exhibited prolonged half-life in vivo than GLP-1
Li, Y., Zheng, X., Tang, L., Xu, W., & Gong, M. (2011) · Peptides · doi:10.1016/j.peptides.2011.04.001 · Cited by 33
Turn Nucleation Perturbs Amyloid β Self-Assembly and Cytotoxicity
Doran, T. M., Anderson, E. A., Latchney, S. E., Opanashuk, L. A., & Nilsson, B. L. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.01.055 · Cited by 32
Meece, J. D. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.pt2.33s · Cited by 32
Morriss-Andrews, A., & Shea, J. (2012) · The Journal of Chemical Physics · doi:10.1063/1.3682986 · Cited by 31
Gu, M., & Viles, J. H. (2016) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2016.04.009 · Cited by 31
The estimation of glutaminyl deamidation and aspartyl cleavage rates in glucagon
Joshi, A. B., & Kirsch, L. E. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.01.006 · Cited by 30
Amyloid formation by salmon calcitonin
Gilchrist, P. J., & Bradshaw, J. P. (1993) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(93)90160-3 · Cited by 29
Methods and models in neurodegenerative and systemic protein aggregation diseases.
Brorsson, A., Kumita, J. R., Ian, M., Bolognesi, B., Speretta, E., Luheshi, L. M., Knowles, T. P. J., Dobson, C. M., & Crowther, D. C. (2010) · PubMed · doi:10.2741/3626 · Cited by 28
Diociaiuti, M., Gaudiano, M. C., & Malchiodi‐Albedi, F. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12129277 · Cited by 28
Gonçalves, P. D. C., Pinheiro, A. S., Romão, L. F., Cortines, J. R., & Follmer, C. (2014) · Amyloid · doi:10.3109/13506129.2014.912208 · Cited by 28
Phosphorylation Interferes with Maturation of Amyloid-β Fibrillar Structure in the N Terminus
Rezaei‐Ghaleh, N., Kumar, S., Walter, J., & Zweckstetter, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.728956 · Cited by 28
Physicochemical Principles of Protein Aggregation
Bolognesi, B., & Tartaglia, G. G. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-386931-9.00003-9 · Cited by 26
Sarangapani, P. S., Weaver, J., Parupudi, A., Besong, T. M. D., Adams, G. G., Harding, S. E., Manikwar, P., Castellanos, M. M., Bishop, S. M., & Pathak, J. A. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.08.020 · Cited by 25
Biochemical Stabilization of Glucagon at Alkaline pH
Caputo, N., Jackson, M. A., Castle, J. R., Youssef, J. E., Bakhtiani, P. A., Bergstrom, C. P., Carroll, J. M., Breen, M. E., Leonard, G. L., David, L. L., et al. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0047 · Cited by 24
Extolling the benefits of molecular therapeutic lipidation
Avadisian, M., & Gunning, P. T. (2013) · Molecular BioSystems · doi:10.1039/c3mb70147f · Cited by 24
Cited by
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Xiao, W., Jiang, W., Chen, Z., Huang, Y., Mao, J., Zheng, W., Hu, Y., & Shi, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02107-5 · Cited by 449
Prebiotic Peptides: Molecular Hubs in the Origin of Life
Frenkel-Pinter, M., Samanta, M., Ashkenasy, G., & Leman, L. J. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00664 · Cited by 354
Karagöz, G. E., Acosta-Alvear, D., & Walter, P. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033886 · Cited by 310
Aggregation of Protein Therapeutics Enhances Their Immunogenicity: Causes and Mitigation Strategies
Lundahl, M. L. E., Fogli, S., Colavita, P. E., & Scanlan, E. M. (2021) · RSC Chemical Biology · doi:10.1039/d1cb00067e · Cited by 212
Metadata
- Authors
- Zapadka, K. L., Becher, F. J., Gomes dos Santos, A. L., & Jackson, S. E.
- Venue
- Interface Focus
- Publisher
- The Royal Society
- Published
- 2017-10-20
- Volume
- 7
- Issue
- 6
- Pages
- 20170030
- ISSN
- 2042-8898 (ISSN-L)
- 2042-8901
- OpenAlex
- W2765546463
- Cited by
- 401
- References
- 216
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.